← Leaderboards
Asaf Alimardanov
National Center For Advancing Translational Sciences
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at National Center For Advancing Translational Sciences
Same institution · by research overlap
Others in their field
Top investigators on “Toxicology”
- Leonard Freedman · Leidos Biomedical Research, Inc.$239,520,687
- David Heimbrook · Leidos Biomedical Research, Inc.$155,080,196
- Barney Sparrow · Battelle Memorial Institute$96,886,832
- Lynn Briscoe · Leidos Biomedical Research, Inc.$93,294,869
- Robert H Vonderheide · University Of Pennsylvania$78,967,264
- Reshan Fernando · Research Triangle Institute$70,521,464
Research focus
ToxicologyFormulationInvestigational DrugsAdme StudyDrug KineticsPharmaceutical PreparationsUnited StatesAcuteClinical TrialsBrainResearch PersonnelLeadAffectPreventChronicBaseSymptomsCessation Of LifeDoseAnimal ModelBrain CellPeptidesPreclinical StudyMedical
Grant awards (48)
Development of Nogo Receptor Decoy for the Treatment of Spinal Cord Injury$3,266,541
ZIA · FY2020 · TR · contact PI
Short Stabilized EPO-Peptide as Therapeutic Agents for Multiple Sclerosis and Acute Brain Trauma$946,223
ZIA · FY2020 · TR · contact PI
Using the Preimplantation Factor (PIF) to Treat Graft-versus-Host Disease$752,003
ZIA · FY2020 · TR · contact PI
IND-Enabling Pre-Clinical Studies of 2DG for Treatment of Epilepsy$301,662
ZIA · FY2020 · TR · contact PI
Development of Nogo Receptor Decoy for the Treatment of Spinal Cord Injury$2,986,554
ZIA · FY2019 · TR · contact PI
HBN-1 Regulated Hypothermia Formulation and Evaluation of Toxicity$1,875,644
ZIA · FY2019 · TR · contact PI
Short Stabilized EPO-Peptide as Therapeutic Agents for Multiple Sclerosis and Acute Brain Trauma$648,002
ZIA · FY2019 · TR · contact PI
Using the Preimplantation Factor (PIF) to Treat Graft-versus-Host Disease$576,445
ZIA · FY2019 · TR · contact PI
Novel Pre-Hospital Therapy of Myocardial Infarction$379,887
ZIA · FY2019 · TR · contact PI
IND-Enabling Pre-Clinical Studies of 2DG for Treatment of Epilepsy$187,652
ZIA · FY2019 · TR · contact PI
Long-Acting Parathyroid Hormone Analog for Treatment of Hypoparathyroidism$149,213
ZIA · FY2019 · TR · contact PI
Development of Nogo Receptor Decoy for the Treatment of Spinal Cord Injury$1,752,658
ZIA · FY2018 · TR · contact PI
HBN-1 Regulated Hypothermia Formulation and Evaluation of Toxicity$944,381
ZIA · FY2018 · TR · contact PI
Using the Preimplantation Factor (PIF) to Treat Graft-versus-Host Disease$502,389
ZIA · FY2018 · TR · contact PI
Short Stabilized EPO-Peptide as Therapeutic Agents for Multiple Sclerosis and Acute Brain Trauma$447,781
ZIA · FY2018 · TR · contact PI
Novel Pre-Hospital Therapy of Myocardial Infarction$245,555
ZIA · FY2018 · TR · contact PI
IND-Enabling Pre-Clinical Studies of 2DG for Treatment of Epilepsy$90,557
ZIA · FY2018 · TR · contact PI
Long-Acting Parathyroid Hormone Analog for Treatment of Hypoparathyroidism$82,252
ZIA · FY2018 · TR · contact PI
Development of Neurosteroids for Lysosomal Storage Disorders$60,985
ZIA · FY2018 · TR · contact PI
Manufacture of RLIP76-LyoPL for Acute Radiation Syndrome$46,927
ZIA · FY2018 · TR · contact PI
Novel Pre-Hospital Therapy of Myocardial Infarction$773,382
ZIA · FY2017 · TR · contact PI
Development of Nogo Receptor Decoy for the Treatment of Spinal Cord Injury$704,803
ZIA · FY2017 · TR · contact PI
Short Stabilized EPO-Peptide as Therapeutic Agents for Multiple Sclerosis and Acute Brain Trauma$405,552
ZIA · FY2017 · TR · contact PI
IND-Enabling Pre-Clinical Studies of 2DG for Treatment of Epilepsy$405,552
ZIA · FY2017 · TR · contact PI
Using the Preimplantation Factor (PIF) to Treat Graft-versus-Host Disease$375,671
ZIA · FY2017 · TR · contact PI
Development of Neurosteroids for Lysosomal Storage Disorders$355,676
ZIA · FY2017 · TR · contact PI
Long-Acting Parathyroid Hormone Analog for Treatment of Hypoparathyroidism$349,442
ZIA · FY2017 · TR · contact PI
HBN-1 Regulated Hypothermia Formulation and Evaluation of Toxicity$343,207
ZIA · FY2017 · TR · contact PI
Manufacture of RLIP76-LyoPL for Acute Radiation Syndrome$318,270
ZIA · FY2017 · TR · contact PI
Novel Pre-Hospital Therapy of Myocardial Infarction$692,020
ZIA · FY2016 · TR · contact PI
Development of Nogo Receptor Decoy for the Treatment of Spinal Cord Injury$623,441
ZIA · FY2016 · TR · contact PI
IND-Enabling Pre-Clinical Studies of 2DG for Treatment of Epilepsy$324,190
ZIA · FY2016 · TR · contact PI
Short Stabilized EPO-Peptide as Therapeutic Agents for Multiple Sclerosis and Acute Brain Trauma$324,190
ZIA · FY2016 · TR · contact PI
Development of Neurosteroids for Lysosomal Storage Disorders$274,314
ZIA · FY2016 · TR · contact PI
Long-Acting Parathyroid Hormone Analog for Treatment of Hypoparathyroidism$268,080
ZIA · FY2016 · TR · contact PI
HBN-1 Regulated Hypothermia Formulation and Evaluation of Toxicity$261,845
ZIA · FY2016 · TR · contact PI
Manufacture of RLIP76-LyoPL for Acute Radiation Syndrome$236,908
ZIA · FY2016 · TR · contact PI
Development of Bone Morphogenetic Protein Inhibitors to Treat Blood and Bone Disorders$205,736
ZIA · FY2016 · TR · contact PI
Development of Nogo Receptor Decoy for the Treatment of Spinal Cord Injury$625,000
ZIA · FY2015 · TR · contact PI
HBN-1 Regulated Hypothermia Formulation and Evaluation of Toxicity$392,679
ZIA · FY2015 · TR · contact PI
Manufacture of RLIP76-LyoPL for Acute Radiation Syndrome$358,333
ZIA · FY2015 · TR · contact PI
Novel Pre-Hospital Therapy of Myocardial Infarction$346,667
ZIA · FY2015 · TR · contact PI
IND-Enabling Pre-Clinical Studies of 2DG for Treatment of Epilepsy$244,500
ZIA · FY2015 · TR · contact PI
Short Stabilized EPO-Peptide as Therapeutic Agents for Multiple Sclerosis and Acute Brain Trauma$228,510
ZIA · FY2015 · TR · contact PI
Development of Neurosteroids for Lysosomal Storage Disorders$206,500
ZIA · FY2015 · TR · contact PI
Development of Bone Morphogenetic Protein Inhibitors to Treat Blood and Bone Disorders$203,571
ZIA · FY2015 · TR · contact PI
Long-Acting Parathyroid Hormone Analog for Treatment of Hypoparathyroidism$180,720
ZIA · FY2015 · TR · contact PI
A Pharmacological and Toxicological Evaluation of the Gene Transfer Vectors sc-rAAV2.5IL-1Ra (Rat) and scr-AAV2.5IL-1Ra (Human) in Rats$179,160
ZIA · FY2015 · TR · contact PI